Form 8-K - Current report:
SEC Accession No. 0001683168-25-005129
Filing Date
2025-07-15
Accepted
2025-07-15 17:19:52
Documents
33
Period of Report
2025-07-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cns_8k.htm   iXBRL 8-K 28301
2 PRESENTATION DATED JULY 2025 cns_ex9901.htm EX-99.1 21073
6 GRAPHIC image_001.jpg GRAPHIC 51751
7 GRAPHIC image_002.jpg GRAPHIC 156416
8 GRAPHIC image_003.jpg GRAPHIC 83448
9 GRAPHIC image_004.jpg GRAPHIC 86906
10 GRAPHIC image_005.jpg GRAPHIC 95224
11 GRAPHIC image_006.jpg GRAPHIC 118681
12 GRAPHIC image_007.jpg GRAPHIC 98287
13 GRAPHIC image_008.jpg GRAPHIC 115881
14 GRAPHIC image_009.jpg GRAPHIC 70736
15 GRAPHIC image_010.jpg GRAPHIC 85156
16 GRAPHIC image_011.jpg GRAPHIC 84362
17 GRAPHIC image_012.jpg GRAPHIC 68477
18 GRAPHIC image_013.jpg GRAPHIC 80422
19 GRAPHIC image_014.jpg GRAPHIC 87260
20 GRAPHIC image_015.jpg GRAPHIC 70728
21 GRAPHIC image_016.jpg GRAPHIC 90384
22 GRAPHIC image_017.jpg GRAPHIC 62917
23 GRAPHIC image_018.jpg GRAPHIC 81627
24 GRAPHIC image_019.jpg GRAPHIC 105096
25 GRAPHIC image_020.jpg GRAPHIC 50350
  Complete submission text file 0001683168-25-005129.txt   2622886

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cnsp-20250715.xsd EX-101.SCH 3017
4 XBRL LABEL FILE cnsp-20250715_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE cnsp-20250715_pre.xml EX-101.PRE 22360
35 EXTRACTED XBRL INSTANCE DOCUMENT cns_8k_htm.xml XML 3688
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

EIN.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39126 | Film No.: 251125669
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)